Bank of New York Mellon’s Nutex Health NUTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.96M Buy
23,151
+1,529
+7% +$194K ﹤0.01% 2575
2026
Q1
$2.05M Buy
21,622
+1,940
+10% +$238K ﹤0.01% 2796
2025
Q4
$3.24M Buy
19,682
+12,075
+159% +$1.6M ﹤0.01% 2575
2025
Q3
$786K Buy
7,607
+386
+5% +$37.9K ﹤0.01% 3350
2025
Q2
$899K Buy
+7,221
New +$933K ﹤0.01% 3186
2023
Q2
Sell
-4,078
Closed -$618K 4443
2023
Q1
$618K Sell
4,078
-44
-1% -$8.91K ﹤0.01% 3377
2022
Q4
$1.17M Buy
4,122
+3,371
+449% +$647K ﹤0.01% 3115
2022
Q3
$169K Buy
751
+70
+10% +$29.7K ﹤0.01% 4077
2022
Q2
$330K Buy
+681
New +$803K ﹤0.01% 3828

Other funds holding NUTX

Bank of New York Mellon's NUTX Position: Q2 2026 in Review

Bank of New York Mellon increased its Nutex Health (NUTX) stake by 7.1% in Q2 2026, buying an estimated $194K and bringing the position to 23,151 shares worth $3.96M. The position accounts for ﹤0.01% of the portfolio, ranked #2575.

Bank of New York Mellon first reported a position in NUTX in Q2 2022 and has held it in 9 quarters since. 99 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Bank of New York Mellon held 23,151 shares of Nutex Health worth $3.96M as of Q2 2026.
  • Bank of New York Mellon bought 1,529 Nutex Health shares in Q2 2026, an estimated $194K.
  • Nutex Health made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2575 holding.
  • Bank of New York Mellon first reported a position in Nutex Health in Q2 2022 and has held it in 9 quarters since.
  • 99 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.